SEC Comment Letter 0000000000-23-014103 to Gritstone bio, Inc. (GRTS) (CIK 0001656634)
Gritstone bio, Inc. (GRTS) (CIK 0001656634)
Date: Dec. 27, 2023 · CIK: 0001656634 · Accession: 0000000000-23-014103
AI Filing Summary & Sentiment
File numbers found in text: 333-276242
Letter
United States securities and exchange commission logo December 27, 2023 Andrew Allen, M.D., Ph.D. Chief Executive Officer Gritstone bio, Inc. 5959 Horton Street, Suite 300 Emeryville, CA 94608 Re:Gritstone bio, Inc. Registration Statement on Form S-3 Filed December 22, 2023 File No. 333-276242 Dear Andrew Allen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Robert Freedman, Esq.
Show Raw Text
United States securities and exchange commission logo
December 27, 2023
Andrew Allen, M.D., Ph.D.
Chief Executive Officer
Gritstone bio, Inc.
5959 Horton Street, Suite 300
Emeryville, CA 94608
Re:Gritstone bio, Inc.
Registration Statement on Form S-3
Filed December 22, 2023
File No. 333-276242
Dear Andrew Allen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Robert Freedman, Esq.